Asia Pacific Lung Cancer Therapy Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Lung Cancer Therapy Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Lung Cancer Therapy Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Lung Cancer Therapy Market Regional Analysis

6.2 Asia Pacific Lung Cancer Therapy Market Revenue 2020-2030 (US$ Million)

6.3 Asia Pacific Lung Cancer Therapy Market Forecast Analysis

7. Asia Pacific Lung Cancer Therapy Market Analysis – by Therapy Type

7.1 Noninvasive and Minimally Invasive

7.1.1 Overview
7.1.2 Noninvasive and Minimally Invasive: Asia Pacific Lung Cancer Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Asia Pacific Lung Cancer Therapy Market Analysis – by Indication

8.1 Non-Small Cell Lung Cancer and Small Cell Lung Cancer

8.1.1 Overview
8.1.2 Non-Small Cell Lung Cancer and Small Cell Lung Cancer: Asia Pacific Lung Cancer Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Asia Pacific Lung Cancer Therapy Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Hospitals: Asia Pacific Lung Cancer Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Oncology Clinics

9.2.1 Overview
9.2.2 Oncology Clinics: Asia Pacific Lung Cancer Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.3 Research Centers

9.3.1 Overview
9.3.2 Research Centers: Asia Pacific Lung Cancer Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Asia Pacific Lung Cancer Therapy Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific

10.2.1 Asia Pacific Lung Cancer Therapy Market Breakdown, by Key Country, 2023 and 2030 (%)
10.2.1.1 Asia Pacific Lung Cancer Therapy Market – Revenue and Forecast Analysis – by Country
10.2.1.1 China: Asia Pacific Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.1.1 China: Asia Pacific Lung Cancer Therapy Market Breakdown, by Therapy Type
10.2.1.1.2 China: Asia Pacific Lung Cancer Therapy Market Breakdown, by Indication
10.2.1.1.3 China: Asia Pacific Lung Cancer Therapy Market Breakdown, by End User

10.2.1.2 India: Asia Pacific Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.2.1 India: Asia Pacific Lung Cancer Therapy Market Breakdown, by Therapy Type
10.2.1.2.2 India: Asia Pacific Lung Cancer Therapy Market Breakdown, by Indication
10.2.1.2.3 India: Asia Pacific Lung Cancer Therapy Market Breakdown, by End User

10.2.1.3 Japan: Asia Pacific Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.3.1 Japan: Asia Pacific Lung Cancer Therapy Market Breakdown, by Therapy Type
10.2.1.3.2 Japan: Asia Pacific Lung Cancer Therapy Market Breakdown, by Indication
10.2.1.3.3 Japan: Asia Pacific Lung Cancer Therapy Market Breakdown, by End User

10.2.1.4 Australia: Asia Pacific Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.4.1 Australia: Asia Pacific Lung Cancer Therapy Market Breakdown, by Therapy Type
10.2.1.4.2 Australia: Asia Pacific Lung Cancer Therapy Market Breakdown, by Indication
10.2.1.4.3 Australia: Asia Pacific Lung Cancer Therapy Market Breakdown, by End User

10.2.1.5 Rest of Asia-Pacific : Asia Pacific Lung Cancer Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Lung Cancer Therapy Market Breakdown, by Therapy Type
10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Lung Cancer Therapy Market Breakdown, by Indication
10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Lung Cancer Therapy Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Advanz Pharma Corp

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bioventus Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Johnson & Johnson

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Medtronic Plc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Meiji Seika Pharma Co Ltd

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Merck KGaA

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Olympus Corp

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 RF Medical Co Ltd

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Sun Pharmaceutical Industries Ltd

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Asia Pacific Lung Cancer Therapy Market

Analysis - By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), and End User (Hospitals, Oncology Clinics, Research Centers, and Others)